Evergreen Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History

Evergreen Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $669,584 - $1.03 Million	-54,086 Closed	0 $0
Q4 2021 Mar 11, 2022	BUY	$16.55 - $27.63 $40,564 - $67,721	2,451 Added 4.75%	54,086 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $1.03 Million - $1.34 Million	-50,370 Reduced 49.38%	51,635 $1.27 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $1.67 Million - $3.37 Million	102,005 New	102,005 $2.65 Million

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Evergreen Capital Management LLC with notifications on news.